Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine
about
Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine
description
clinical trial
@en
klinisch onderzoek
@nl
name
Dose Ranging Study of GSK12657 ...... by GSK1265744 Plus Rilpivirine
@en
type
label
Dose Ranging Study of GSK12657 ...... by GSK1265744 Plus Rilpivirine
@en
prefLabel
Dose Ranging Study of GSK12657 ...... by GSK1265744 Plus Rilpivirine
@en
P1476
A Phase IIb, Dose Ranging Stud ...... l Therapy Naive Adult Subjects
@en
P17
P3098
NCT01641809
P4844
P580
2012-08-06T00:00:00Z
P582
2013-10-10T00:00:00Z